| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 153.858 | 111.815 | 24.983 | 4 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 154.902 | 112.838 | 25.045 | 2.318 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 152.952 | 116.082 | 31.927 | 4.262 | 747 | 884 | 343 | 0 | 0 | 0 |
| Gross Profit/Loss - EUR | 1.949 | -3.243 | -6.882 | -1.944 | -747 | -884 | -343 | 0 | 0 | 0 |
| Net Profit/Loss - EUR | 1.297 | -3.243 | -6.912 | -2.014 | -747 | -884 | -343 | 0 | 0 | 0 |
| Employees | 3 | 3 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Farmedica S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.721 | 1.437 | 3.494 | 2.779 | 1.054 | 1.034 | 1.011 | 1.014 | 1.011 | 1.005 |
| Current Assets | 66.330 | 24.984 | 952 | 1.142 | 1.307 | 1.369 | 1.400 | 1.404 | 1.400 | 1.513 |
| Inventories | 30.581 | 16.552 | 0 | 0 | -127 | -125 | -122 | -122 | -122 | 0 |
| Receivables | 16.140 | 4.510 | 340 | 1.134 | 1.091 | 1.238 | 1.276 | 1.280 | 1.276 | 1.269 |
| Cash | 19.609 | 3.921 | 612 | 8 | 343 | 256 | 246 | 247 | 246 | 244 |
| Shareholders Funds | 23.121 | -3.190 | -10.048 | -11.877 | -12.394 | -13.044 | -13.098 | -13.139 | -13.099 | -13.026 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 44.931 | 29.610 | 14.494 | 15.798 | 14.754 | 15.446 | 15.508 | 15.557 | 15.509 | 15.544 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Farmedica S.r.l.